Page last updated: 2024-10-27

flumazenil and Autosomal Dominant Myotubular Myopathy

flumazenil has been researched along with Autosomal Dominant Myotubular Myopathy in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabrera-Serrano, M1
Mavillard, F1
Biancalana, V1
Rivas, E1
Morar, B1
Hernández-Laín, A1
Olive, M1
Muelas, N1
Khan, E1
Carvajal, A1
Quiroga, P1
Diaz-Manera, J1
Davis, M1
Ávila, R1
Domínguez, C1
Romero, NB1
Vílchez, JJ1
Comas, D1
Laing, NG1
Laporte, J1
Kalaydjieva, L1
Paradas, C1

Other Studies

1 other study available for flumazenil and Autosomal Dominant Myotubular Myopathy

ArticleYear
A Roma founder
    Neurology, 2018, 07-24, Volume: 91, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Child; Cohort Studies; Founder Effect; Huma

2018